Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection. | J Clin Invest | 2022 | 35763348 | PubTator, text mining | PubMed |
| Fc-Mediated Functions of Porcine IgG Subclasses. | Front Immunol | 2022 | 35757698 | PubTator, text mining | PubMed |
| Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment. | Front Cell Dev Biol | 2022 | 35757002 | PubTator, text mining | PubMed |
| The Potential Diagnostic Value of Immune-Related Genes in Interstitial Fibrosis and Tubular Atrophy after Kidney Transplantation. | J Immunol Res | 2022 | 35755170 | PubTator, text mining | PubMed |
| New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells. | Viruses | 2022 | 35746616 | PubTator, text mining | PubMed |
| Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19. | Cell Rep | 2022 | 35738278 | PubTator, text mining | PubMed |
| Role of the cGAS-STING pathway in systemic and organ-specific diseases. | Nat Rev Nephrol | 2022 | 35732833 | PubTator, text mining | PubMed |
| Hypoxia-inducible lentiviral gene expression in engineered human macrophages. | J Immunother Cancer | 2022 | 35728871 | PubTator, text mining | PubMed |
| Antibodies to combat viral infections: development strategies and progress. | Nat Rev Drug Discov | 2022 | 35725925 | PubTator, text mining | PubMed |
| Temporal Modulation of Drug Desensitization Procedures. | Curr Issues Mol Biol | 2022 | 35723342 | PubTator, text mining | PubMed |
| Genome-Wide Placental Gene Methylations in Gestational Diabetes Mellitus, Fetal Growth and Metabolic Health Biomarkers in Cord Blood. | Front Endocrinol (Lausanne) | 2022 | 35721735 | PubTator, text mining | PubMed |
| The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged Humans. | Front Aging Neurosci | 2022 | 35721016 | PubTator, text mining | PubMed |
| From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement. | Front Immunol | 2022 | 35720368 | PubTator, text mining | PubMed |
| Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection. | Front Immunol | 2022 | 35711449 | PubTator, text mining | PubMed |
| SHC1 Promotes Lung Cancer Metastasis by Interacting with EGFR. | J Oncol | 2022 | 35706930 | PubTator, text mining | PubMed |
| Preclinical Characterization of ASP2713, a Novel Igβ and FcγRIIB Cross-Linking Antibody, for Prediction of Human Pharmacokinetics and Clinically Effective Dose. | J Pharm Sci | 2022 | 35700799 | PubTator, text mining | PubMed |
| Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis. | Sci Rep | 2022 | 35697739 | PubTator, text mining | PubMed |
| Mucosa-Colonizing Microbiota Correlate With Host Autophagy Signaling in Patients With Inflammatory Bowel Disease. | Front Microbiol | 2022 | 35694307 | PubTator, text mining | PubMed |
| Fc receptors and the diversity of antibody responses to HIV infection and vaccination. | Genes Immun | 2022 | 35688931 | PubTator, text mining | PubMed |
| DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity. | J Immunother Cancer | 2022 | 35688554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=45